Status:

UNKNOWN

Augmentation of Screening Colonoscopy With Fecal Immunochemical Testing

Lead Sponsor:

Forsyth Medical Center

Conditions:

Colon Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The study will determine if adding fecal immunochemical testing (FIT) at yearly intervals to a colonoscopy screening program will improve colon cancer detection rates.

Detailed Description

This study will evaluate the benefit of augmenting a compliant College of Gastroenterology colorectal cancer screening program with the addition of yearly FIT testing at two critical points in the cur...

Eligibility Criteria

Inclusion

  • Group I (positive colonoscopy)
  • 18 to 75 years of age
  • male or female
  • willing to provide written informed consent
  • In the event that the colonoscopy is incomplete, or polypectomy is partial, the above patients are eligible if a successful examination is completed within 6 months of the inadequate exam.
  • Group II (negative colonoscopy)
  • 50 to 69 years of age
  • Male or female
  • Willing to provide written informed consent
  • In the event that the colonoscopy is incomplete, the patient is eligible if a successful examination is completed within 6 months of the inadequate exam.

Exclusion

  • Group I (positive colonoscopy)
  • chronic use of coumadin
  • history of previous GI malignancy, inflammatory bowel disease (Crohns disease, ulcerative colitis)
  • age or health status contraindicates repeat colonoscopy
  • history of Familial Polyposis or Hereditary Nonpolyposis Colon Cancer Syndrome
  • The index colonoscopy resulted in a perforation requiring surgical repair
  • An otherwise qualifying colonoscopy is followed by a recommendation for repeat colonoscopy in ≤ 1 yr.
  • Group II (negative colonoscopy)
  • chronic use of coumadin
  • history of previous GI malignancy, inflammatory bowel disease (Crohns disease, ulcerative colitis)
  • age or health status contraindicates repeat colonoscopy
  • history of Familial Polyposis or Hereditary Nonpolyposis Colon Cancer Syndrome
  • The index colonoscopy resulted in a perforation requiring surgical repair
  • Significant family history resulting in a recommendation for repeat colonoscopy in 5 years or less

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2020

Estimated Enrollment :

4100 Patients enrolled

Trial Details

Trial ID

NCT00892593

Start Date

May 1 2009

End Date

May 1 2020

Last Update

July 21 2014

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Digestive Health Specialists, PA

Winston-Salem, North Carolina, United States, 27103

2

Piedmont Gastroenterology Specialists, PA

Winston-Salem, North Carolina, United States, 27103

3

Salem Gastroenterology Associates, PA

Winston-Salem, North Carolina, United States, 27103

Augmentation of Screening Colonoscopy With Fecal Immunochemical Testing | DecenTrialz